Fresenius SE & Co KGaA | 36.32 / +2.85% |
Date/Time | 03/08 / 12:19 |
Chg. / Chg.(%) | 1.01 / +2.85% |
Bid | 36.00 / 228 |
Ask | 36.05 / 232 |
Open | 36.40 |
Previous Close | 35.31 |
High | 36.40 |
Low | 36.32 |
Volume [EUR] | 14,803.41 |
Volume [Units] | 407 |
Price fixings | 2 |
ISIN | DE0005785604 |
Security | FRE/D |
Exchange | Cboe Europe CXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 36.220 | ![]() |
518,732 |
Cboe Europe .. | 36.23 | ![]() |
147,646 |
London Inter.. | 36.22 | ![]() |
104,343 |
TradeGate | 36.260 | ![]() |
62,352 |
Turquoise | 36.23 | ![]() |
54,506 |
gettex | 36.190 | ![]() |
34,002 |
Stuttgart | 36.270 | ![]() |
10,771 |
Cboe Europe .. | 36.27 | ![]() |
3,192 |
Hamburg | 36.490 | ![]() |
1,770 |
Frankfurt | 36.2400 | ![]() |
1,683 |
Cboe Europe .. | 36.32 | ![]() |
407 |
Hannover | 36.370 | ![]() |
359 |
München | 36.330 | ![]() |
106 |
Berlin | 36.380 | ![]() |
97 |
Borsa Italia.. | 36.530 | ![]() |
58 |
Vienna Globa.. | 36.36 | ![]() |
13 |
Düsseldorf | 36.260 | ![]() |
0 |
Lang & Schwa.. | 36.220 | ![]() |
|
Nasdaq Other.. | 42.8000 | 262 | |
Mexico | 877.05 | ![]() |
2,351 |
EUREX | Options |
News
- Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus
07:00 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/11/2019 / 23:35 - GlobeNewswire - eGenesis Announces $100 Million Series B Financing
11/07/2019 / 12:00 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/04/2019 / 23:27 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
10/29/2019 / 18:45 - GlobeNewswire